The Europe alopecia (hair loss) treatment market is projected to grow with a CAGR of 4.45% over the estimated period of 2021 to 2028. Changing lifestyle patterns, the increased prevalence of autoimmune conditions, high levels of alcohol consumption and smoking, and the surging aging population are among the key factors accredited to the region’s market growth.

EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET FORECAST 2021-2028

Asia Pacific Alopecia (Hair Loss) Treatment Market by Gender (Female, Male) Market by Indications (Androgenic Alopecia, Alopecia Areata, Alopecia Totalis, Other Indications) Market by Distribution Channels (Drug Stores & Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) Market by Treatment (Topical, Oral, Other Treatment Types) by Geography.

Request free sample

The Europe alopecia (hair loss) treatment market is projected to grow with a CAGR of 4.45% over the estimated period of 2021 to 2028. Changing lifestyle patterns, the increased prevalence of autoimmune conditions, high levels of alcohol consumption and smoking, and the surging aging population are among the key factors accredited to the region’s market growth.europe-alopecia-hair-loss-treatment-market

To know more about this report, request a free sample copy

The Europe alopecia (hair loss) treatment market growth analysis constitutes the study of France, Germany, Italy, Russia, the United Kingdom, Poland, Belgium, and the rest of Europe. Alopecia is mainly caused due to medical conditions such as hyperthyroidism and cancer. The United Kingdom observes an increasing incidence of cancer annually. As per Cancer Research UK, the prevalence rates for all cancers are anticipated to increase by 2% in the country from 2014 to 2035, equating to nearly 742 cases per 100,000 individuals. This factor is expected to raise the cases of alopecia in the United Kingdom.

In Germany, consumers are highly concerned about personal appearance and grooming and spend significantly on products such as hair care. However, baldness is a major issue in the country. As per the German Medical Group, men opt for hair transplantation in Germany owing to the increasing problem of baldness and hair fall. Hence, these factors are anticipated to play a pivotal role in propelling the alopecia (hair loss) treatment market growth in Europe during the forecasting years.

The Himalaya Drug Company, headquartered in India, manufactures health care products with Ayurvedic ingredients. The firm’s product offering includes baby care, well-being, personal care, pharmaceuticals, animal health products, and nutrition. It has offices in the United States, Europe, India, the Middle East, South East Asia, and South Africa. The offices monitor and manage the distribution as well as the marketing of the Himalaya range to 88 countries.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • RISE IN AUTOIMMUNE DISEASES
        • HIGH CONSUMPTION OF ALCOHOL AND TOBACCO
        • UNHEALTHY DIETARY HABITS
        • STRESS AND CHANGING LIFESTYLES
      • KEY RESTRAINTS
        • RISK OF INFECTIONS OR SIDE EFFECTS
        • HIGH COSTS
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON ALOPECIA (HAIR LOSS) TREATMENT MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY GENDER
      • FEMALE
      • MALE
    3. MARKET BY INDICATIONS
      • ANDROGENIC ALOPECIA
      • ALOPECIA AREATA
      • ALOPECIA TOTALIS
      • OTHER INDICATIONS
    4. MARKET BY DISTRIBUTION CHANNELS
      • DRUG STORES & RETAIL PHARMACIES
      • HOSPITAL PHARMACIES
      • ONLINE PHARMACIES
    5. MARKET BY TREATMENT
      • TOPICAL
        • MINOXIDIL
        • SHAMPOOS
      • ORAL
        • FINASTERIDE
        • OTHER ORAL HAIR LOSS TREATMENT
      • OTHER TREATMENT TYPES
    6. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS & DIVESTITURES
      • COMPANY PROFILES
        • ACLARIS THERAPEUTICS
        • CELLMID
        • CIPLA LTD
        • CONCERT PHARMACEUTICALS
        • DAIICHI SANKYO
        • REDDY’S LABORATORIES
        • JOHNSON AND JOHNSON
        • LEXINGTON INTERNATIONAL
        • MERK & CO INC
        • SHISEIDO COMPANY LIMITED
        • SUN PHARMACEUTICAL INDUSTRIES LTD
        • TAISHO PHARMACEUTICALS CO LTD THE HIMALAYA DRUG COMPANY
        • TEVA PHARMACEUTICALS INDUSTRIES LTD
        • THE HIMALAYA DRUG COMPANY
        • TRANSITION HAIR PVT LTD

    TABLE LIST

    TABLE 1: MARKET SNAPSHOT – ALOPECIA (HAIR LOSS) TREATMENT MARKET

    TABLE 2: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY GENDER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY GENDER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY INDICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY INDICATIONS, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DISTRIBUTION CHANNELS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: EUROPE L ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DISTRIBUTION CHANNELS, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 12: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 15: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 16: LEADING PLAYERS OPERATING IN EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET

    TABLE 17: LIST OF MERGERS & ACQUISITIONS

    TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 20: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

    FIGURES LIST 

    FIGURE 1: PREVALENCE OF DIAGNOSED AUTOIMMUNE CONDITIONS IN SELECTED COUNTRIES 2019

    FIGURE 2: KEY MARKET TRENDS

    FIGURE 3: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 4: OPPORTUNITY MATRIX

    FIGURE 5: VENDOR LANDSCAPE

    FIGURE 6: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY GENDER, IN 2020

    FIGURE 7: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

    FIGURE 8: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

    FIGURE 9: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY INDICATIONS, IN 2020

    FIGURE 10: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ANDROGENIC ALOPECIA, 2021-2028 (IN $ MILLION)

    FIGURE 11: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ALOPECIA AREATA, 2021-2028 (IN $ MILLION)

    FIGURE 12: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ALOPECIA TOTALIS, 2021-2028 (IN $ MILLION)

    FIGURE 13: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER INDICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 14: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNELS, IN 2020

    FIGURE 15: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DRUG STORES & RETAIL PHARMACIES, 2021-2028 (IN $ MILLION)

    FIGURE 16: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY HOSPITAL PHARMACIES, 2021-2028 (IN $ MILLION)

    FIGURE 17: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ONLINE PHARMACIES, 2021-2028 (IN $ MILLION)

    FIGURE 18: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY TREATMENT, IN 2020

    FIGURE 19: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL, 2021-2028 (IN $ MILLION)

    FIGURE 20: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY TOPICAL HAIR LOSS TREATMENT, IN 2020

    FIGURE 21: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY MINOXIDIL, 2021-2028 (IN $ MILLION)

    FIGURE 22: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY SHAMPOOS, 2021-2028 (IN $ MILLION)

    FIGURE 23: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL, 2021-2028 (IN $ MILLION)

    FIGURE 24: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY ORAL HAIR LOSS TREATMENT, IN 2020

    FIGURE 25: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY FINASTERIDE, 2021-2028 (IN $ MILLION)

    FIGURE 26: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER ORAL HAIR LOSS TREATMENT, 2021-2028 (IN $ MILLION)

    FIGURE 27: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER TREATMENT TYPES, 2021-2028 (IN $ MILLION)

    FIGURE 28: EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 29: UNITED KINGDOM ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 30: GERMANY ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 31: FRANCE ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 32: ITALY ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 33: RUSSIA ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 34: BELGIUM ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 35: POLAND ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 36: REST OF EUROPE ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. MARKET BY GENDER
      • FEMALE
      • MALE
    2. MARKET BY INDICATIONS
      • ANDROGENIC ALOPECIA
      • ALOPECIA AREATA
      • ALOPECIA TOTALIS
      • OTHER INDICATIONS
    3. MARKET BY DISTRIBUTION CHANNELS
      • DRUG STORES & RETAIL PHARMACIES
      • HOSPITAL PHARMACIES
      • ONLINE PHARMACIES
    4. MARKET BY TREATMENT
      • TOPICAL
        • MINOXIDIL
        • SHAMPOOS
      • ORAL
        • FINASTERIDE
        • OTHER ORAL HAIR LOSS TREATMENT
      • OTHER TREATMENT TYPES

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type